Actavis Mid-Atlantic, LLC.
FDA-inspected organization
Actavis Mid-Atlantic, LLC. has been audited by the FDA 26 times between 2000 and 2014 across all 2 sites.
Documents

FDA 483 Actavis Mid-Atlantic, LLC., Owings Mills | 2014
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Owings Mills | 2008
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2006
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2004
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2002
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2002
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2002
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Owings Mills | 2002
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2001
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Owings Mills | 2001
Out of stock

FDA 483 Actavis Mid-Atlantic, LLC., Lincolnton | 2000
Out of stock
FDA Investigators (30)
- Rachel C. Harrington, FDA Investigator
- Steven P. Donald, FDA Investigator
- Tajah L. Blackburn, FDA Investigator
- Tracy R. Ball, FDA Investigator
- Eileen J. Bannerman, FDA Investigator
- Patric C. Klotzbuecher, FDA Investigator
- Ernest Bizjak, FDA Investigator
- Merideth K. Rose, FDA Investigator
- Brooke K. Higgins, FDA Investigator
- Lori S. Lawless, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Melissa J. Garcia, FDA Investigator
- Kenneth M. Gordon, FDA Investigator
- Walter L. Fava, FDA Investigator
- Rebecca Rodriguez, FDA Investigator
- Tiffani D. Wilson, FDA Investigator
- George Pyramides, FDA Investigator
- Gerald B. Seaborn, FDA Investigator
- Suzanne M. Healy, FDA Investigator
- Kenneth Nieves, FDA Investigator
- Alicia M. Mozzachio, FDA Investigator
- Yvonne C. McKnight, FDA Investigator
- Matthew M. Henciak, FDA Investigator
- Donald L. Lech, FDA Investigator
- Jose R. Hernandez, FDA Investigator
- Wanda Y. Honeyblue, FDA Investigator
- Chryste D. Best, FDA Investigator
- Lynette P. Salisbury, FDA Investigator
- Diane T. Bargo, FDA Investigator
- Lori A. Holmquist, FDA Investigator
